Migraine Headaches: Clinical Trials

21 trials for Migraine Headaches, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

16 completed, 3 terminated, 1 active not recruiting, 1 withdrawn. 7 Not applicable, 4 Phase 4, 3 Phase 1, 3 Phase 2, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable7Completed 6, Active not recruiting 1
Phase 44Terminated 3, Withdrawn 1
Phase 13Completed 3
Phase 23Completed 3
Phase 33Completed 3

Follow Migraine Headaches: new trials by email Literature Review of Migraine Headaches trials Research Report on Migraine Headaches

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Yogabased Movements for Primary Headaches (Migraine and/or Cluster Headache) - YOURHEAD - a Pilot Study
Intervention yogabased movements - Cluster Headache - Episodic and Chronic, Migraine Headache
Not applicableActive not recruitingKarolinska Institutet202026-01-012026-09-23
Acute Migraine Treatment in the ED With Gepants
Rimegepant, Zavegepant - Migraine Headaches
Phase 4TerminatedIcahn School of Medicine at Mount Sinai92025-06-052026-04-29
Effect of Breathing Techniques on Migraine Attacks and Severity
breathing techniques - Migraine Headaches, Breathing Techniques
Not applicableCompletedDokuz Eylul University862022-11-012024-09-19
The Efficacy of Neurofeedback Mindfulness in Migraine Management
Neurofeedback mindfulness, Simple attention controlled task - Migraine Headaches
Not applicableCompletedUniversity of Saskatchewan1012021-09-092024-04-02
An Efficacy and Safety Study of DFN-02 (Sumatriptan Nasal Spray 10 mg)
Sumatriptan 10 mg Nasal Spray, Sumatriptan Placebo Nasal Spray - Migraine Headaches
Phase 2CompletedUpsher-Smith Laboratories1072016-07-112021-03-30
Prospective, Multi-Center Evaluation of the Efficacy of Peripheral Trigger Decompression Surgery for Migraine Headaches
Botulinum Toxin Type A, Surgery, Daily headache diary - Migraine Headaches
Not applicableCompletedOhio State University442015-09-012024-04-22
Study to Determine the Efficacy and Safety of ELS-M11 in Acute Migraine
ELS-M11, Placebo - Migraine Headaches
Phase 1 / Phase 2CompletedAchelios Therapeutics482014-03-012017-07-11
Theramine® in the Prevention of Migraine Headache
Theramine (medical food/old drug), Placebo (l-alanine) - Migraine Headaches
Phase 4TerminatedVincent Martin, MD312013-11-012016-05-05
Haldol/Diphenhydramine Versus Metoclopramide/Diphenhydramine for Treatment of Acute Headache in the ED: A RCT
Haloperidol, Metoclopramide 10mg, Diphenhydramine - Migraine Headaches, Nausea
Phase 4WithdrawnUnited States Naval Medical Center, Portsmouth2013-06-122025-07-29
The Utility of Telemedicine in the Management of Migraine
Migraine Headaches
CompletedUniversity of Texas Southwestern Medical Center452012-10-012019-10-25
Prochlorperazine Versus Acetaminophen, Aspirin, and Caffeine for the Treatment of Acute Migraine
Aspirin, Acetaminophen, Caffeine pills, Prochlorperazine 10mg - Migraine Headaches
Phase 4TerminatedAlbert Einstein Healthcare Network932010-11-012020-03-18
Peer Mentorship: An Intervention To Promote Effective Pain Self-Management In Adolescents
Mentorship - Irritable Bowel Syndrome (IBS), Functional Abdominal Pain
Not applicableCompletedUniversity of California, Los Angeles272009-12-012016-09-30
Set Point Acupuncture for Migraines Using a Digital Assistant
acupuncture - Migraine Headaches
Phase 1CompletedMemorial Medical Center502008-07-012013-07-12
Patent Foramen Ovale in Children With Migraine Headaches
Migraine Headaches
CompletedUniversity of Utah1092008-04-012017-12-26
Craniosacral Therapy in Migraine: A Feasibility Study
Craniosacral therapy, Low strength static magnets - Migraine Headaches
Not applicableCompletedUniversity of North Carolina, Chapel Hill662006-09-012012-12-04
PREMIUM Migraine Trial
Sham Procedure, AMPLATZER PFO Occluder - Migraine Headaches, Patent Foramen Ovale
Not applicableCompletedAbbott Medical Devices2302006-01-012020-07-30
To Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migraine Headaches
sumatriptan, naproxen sodium - Migraine Headaches
Phase 3CompletedPOZEN14002004-08-012007-02-12
To Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migrane Headaches
sumatriptan, naproxen sodium - Migraine Headaches
Phase 3CompletedPOZEN12002004-07-012007-02-12
The Safety Of Combo Formulation In The Treatment Of Multiple Episodes Of Acute Migraine Over 12 Months
Sumatriptan and Naproxen sodium - Migraine Headaches
Phase 3CompletedPOZEN5002004-05-012007-03-01
A Study of the Efficacy of RWJ-333369 in the Prevention of Migraine
RWJ-333369 - Migraine Headaches
Phase 2CompletedSK Life Science, Inc.3002002-03-012012-08-02

Showing 20 of 21. Sign in to see all of them.

Narrower conditions

Migraine Disorders (21)  ·  Headache (4)  ·  Epilepsy (2)  ·  Agnosia (1)  ·  Behavior (1)  ·  Bronchiolitis Obliterans Syndrome (1)  ·  Chest Pain (1)  ·  Chronic Pain (1)  ·  Cluster Headache (1)  ·  Complex Regional Pain Syndromes (1)  ·  Emergencies (1)  ·  Facial Pain (1)  ·  Fibromyalgia (1)  ·  Foramen Ovale, Patent (1)  ·  Headache Disorders (1)

Broader conditions

Brain Diseases (21)  ·  Central Nervous System Diseases (21)  ·  Headache Disorders, Primary (21)  ·  Nervous System Diseases (21)  ·  Headache Disorders (20)  ·  Pathological Conditions, Signs and Symptoms (9)  ·  Neurologic Manifestations (8)  ·  Signs and Symptoms (8)  ·  Pain (5)  ·  Cardiovascular Diseases (2)  ·  Neurobehavioral Manifestations (2)  ·  Aberrant Motor Behavior in Dementia (1)  ·  Autonomic Nervous System Diseases (1)  ·  Behavior (1)  ·  Behavioral Symptoms (1)

Interventions

Sumatriptan (4)  ·  Naproxen (3)  ·  Acetaminophen (1)  ·  Acupuncture Therapy (1)  ·  Alanine (1)  ·  Aspirin (1)  ·  Botulinum Toxins, Type A (1)  ·  Diphenhydramine (1)  ·  Educational Status (1)  ·  Haloperidol (1)  ·  Ketoprofen (1)  ·  Metoclopramide (1)  ·  Nadolol (1)  ·  Nasal Sprays (1)  ·  Palliative Care (1)

Sponsors

POZEN (3)  ·  Abbott Medical Devices (1)  ·  Achelios Therapeutics (1)  ·  Albert Einstein Healthcare Network (1)  ·  Dokuz Eylul University (1)  ·  Icahn School of Medicine at Mount Sinai (1)  ·  Karolinska Institutet (1)  ·  Memorial Medical Center (1)  ·  Ohio State University (1)  ·  SK Life Science, Inc. (1)  ·  Sandoz (1)  ·  United States Naval Medical Center, Portsmouth (1)  ·  University of California, Los Angeles (1)  ·  University of North Carolina, Chapel Hill (1)  ·  University of Saskatchewan (1)

Countries

United States (17)  ·  Canada (1)  ·  Sweden (1)  ·  Turkey (Türkiye) (1)

Top investigators

David Taylor (3)  ·  Andrew Charles, MD (1)  ·  Crist J. Frangakis, Ph.D. (1)  ·  Deborah Friedman, MD (1)  ·  James Bale, MD (1)  ·  John Douglas Mann, MD (1)  ·  Jonathan Schimmel (1)  ·  Jonathan Tobis, M.D. (1)  ·  Kenneth Deitch, DO (1)  ·  Lonnie K. Zeltzer, MD (1)  ·  LuAnn Minich, MD (1)  ·  Matthew Gaffigan, MD (1)  ·  Rachel McCandless, MD (1)  ·  Sagar Munjal, MD (1)

Results publications

PMID 17405970, PMID 10331688, PMID 11472723, PMID 11807151, PMID 15111681, PMID 16148260, PMID 16188533, PMID 16362702, PMID 16373630, PMID 16963692, PMID 1727198, PMID 17295330, PMID 17478165, PMID 17541126, PMID 17927647, PMID 18541041, PMID 19222595, PMID 21600053, PMID 29191325, PMID 29878341, PMID 30877622, PMID 31450969, PMID 6694427, PMID 6784664, PMID 7908596, PMID 9774749

NIH funding

R21AT002750 (1)